
Chemical and Pharmaceutical Bulletin p. 740 - 742 (2000)
Update date:2022-08-03
Topics:
O'Connell, Celeste E.
Rowell, Cheryl A.
Ackermann, Karen
Garcia, Ana Maria
Lewis, Michael D.
Kowalczyk, James J.
CA1A2X peptidomimetics containing a modified proline at position A2 were prepared and evaluated for their ability to inhibit farnesyltransferase (FTase) and geranylgeranyltransferase I (GGTase I) in enzymatic and cell- bas
View Morewebsite:http://www.antaibio.com
Contact:0086-21-65663057
Address:Room 2108, Building 2,No. 489 Zhengli Road,200433
Yuan Shi(SuQian)Biotechnology Co.,Ltd
website:http://www.yuanshibio.com
Contact:+86-527-84226672
Address:jiangsu suqian
Wuhan Sunrise Pharmaceutical Technology Co., Ltd
Contact:+86-27-83314682
Address:Room 340, New material Industrial base No.17, Gu Tian Five Lu , Qiaokou District, Wuhan , China
chengdu firsterchem Pharmaceutical Co., Ltd.
Contact:028-66825849
Address:chengdu
Fujian Xianyangyang Biotechnology Inc.
Contact:86-593-2805888
Address:No.23 Ningchuan North Road, Ningde, Fujian, China
Doi:10.1021/jm00297a029
(1970)Doi:10.1002/cbdv.201800189
(2019)Doi:10.1007/s10895-013-1286-7
(2014)Doi:10.1016/j.jinorgbio.2018.09.009
(2018)Doi:10.1021/jo802339t
(2009)Doi:10.1107/S0108270100003760
(2000)